Anlon Healthcare Limited (AHCL.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹24.40 (-1.29%) as of
Key statistics
- Market cap
- 12.97B
- P/E (TTM)
- 35.88
- EPS (TTM)
- 0.68
- Dividend yield
- 0.00%
- 52-week range
- 10.28 – 37.60
- Revenue (TTM)
- 2.26B
- Profit margin
- 13.98%
- Volume
- 533.37k
About Anlon Healthcare Limited
Anlon Healthcare Limited manufactures and sells active pharmaceutical ingredients in India and internationally. The company also offers bulk drugs; advanced pharmaceutical intermediates; nutraceutical API products; and drug intermediates. It also manufactures loxoprofen sodium dihydrate, ketoprofen, and dexketoprofen trometamol products for pain management and anti-inflammatory therapies. Anlon Healthcare Limited was incorporated in 2013 and is based in Rajkot, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Rajkot, India
- Employees
- 119
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- IDBI MUTUAL FUND - IDBI GOLD E (LICMFGOLD.BO)
- IGARASHI MOTORS INDIA LTD. (IGARASHI.BO)
- SUNDARAM MULTI PAP LTD (SUNDARAM.NS)
- DCM SHRIRAM INTERNATNL L (DCMSIL.NS)
- REETECH INTERNATIONAL LIMITED (REETECH.BO)
- CDG PETCHEM LIMITED (CDG.BO)
- EXCEL INDUSTRIES LTD. (EXCELINDUS.BO)
- SIDDHI COTSPIN LIMITED (SIDDHICOTS-SM.NS)